221 related articles for article (PubMed ID: 31650962)
1. Percutaneous sclerotherapy with gelified ethanol of low-flow vascular malformations of the head and neck region: preliminary results.
Ierardi AM; Colletti G; Biondetti P; Dessy M; Carrafiello G
Diagn Interv Radiol; 2019 Nov; 25(6):459-464. PubMed ID: 31650962
[TBL] [Abstract][Full Text] [Related]
2. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
3. Ethanol sclerotherapy of head and neck venous malformations.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Krutman M; Wolosker N
Einstein (Sao Paulo); 2014 Apr; 12(2):181-6. PubMed ID: 25003923
[TBL] [Abstract][Full Text] [Related]
4. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
Teusch VI; Wohlgemuth WA; Hammer S; Piehler AP; Müller-Wille R; Goessmann H; Uller W
AJR Am J Roentgenol; 2017 Dec; 209(6):1390-1395. PubMed ID: 28929808
[TBL] [Abstract][Full Text] [Related]
6. Direct intralesional ethanol sclerotherapy of extensive venous malformations with oropharyngeal involvement after a temporary tracheotomy in the head and neck: Initial results.
Wang D; Su L; Han Y; Wang Z; Zheng L; Li J; Fan X
Head Neck; 2017 Feb; 39(2):288-296. PubMed ID: 27653619
[TBL] [Abstract][Full Text] [Related]
7. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations.
Dompmartin A; Blaizot X; Théron J; Hammer F; Chene Y; Labbé D; Barrellier MT; Gaillard C; Leroyer R; Chedru V; Ollivier C; Vikkula M; Boon LM
Eur Radiol; 2011 Dec; 21(12):2647-56. PubMed ID: 21822948
[TBL] [Abstract][Full Text] [Related]
8. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
Lee IH; Kim KH; Jeon P; Byun HS; Kim HJ; Kim ST; Kim YW; Kim DI; Choi JY
Korean J Radiol; 2009; 10(3):269-76. PubMed ID: 19412515
[TBL] [Abstract][Full Text] [Related]
9. [Head and neck superficial venous malformations].
Sigaux N; Viremouneix L; Guibaud L; Breton P
Rev Stomatol Chir Maxillofac Chir Orale; 2015 Sep; 116(4):201-8. PubMed ID: 26296277
[TBL] [Abstract][Full Text] [Related]
10. Quantitative volumetric analysis of head and neck venous and lymphatic malformations to assess response to percutaneous sclerotherapy.
Alexander MD; McTaggart RA; Choudhri OA; Pandit RP; Wu A; Ross M; Do HM
Acta Radiol; 2016 Feb; 57(2):205-9. PubMed ID: 25788316
[TBL] [Abstract][Full Text] [Related]
11. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
12. Multimodality Image-Guided Sclerotherapy of Low-Flow Orbital Vascular Malformations: Report of Single-Center Experience.
Harmoush S; Chinnadurai P; El Salek K; Metwalli Z; Herce H; Bhatt A; Steinkuller P; Vece T; Siddiqui S; Pimpalwar A; Marx D; Mawad M; Pimpalwar S
J Vasc Interv Radiol; 2016 Jul; 27(7):987-995.e4. PubMed ID: 27184528
[TBL] [Abstract][Full Text] [Related]
13. MRI-guided percutaneous sclerotherapy of venous malformations: initial clinical experience using a 3T MRI system.
O'Mara DM; Berges AJ; Fritz J; Weiss CR
Clin Imaging; 2020 Sep; 65():8-14. PubMed ID: 32353719
[TBL] [Abstract][Full Text] [Related]
14. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy of peripheral low-flow vascular malformations: technical aspects and mid-term clinical outcome.
Giurazza F; Corvino F; Cangiano G; Amodio F; Cavaglià E; Silvestre M; De Magistris G; Tecame S; Niola R
Radiol Med; 2018 Jun; 123(6):474-480. PubMed ID: 29476439
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
[TBL] [Abstract][Full Text] [Related]
17. MR-guided percutaneous sclerotherapy of low-flow vascular malformations: Clinical experience using a 1.5 tesla MR system.
O'Mara DM; DiCamillo PA; Gilson WD; Herzka DA; Wacker FK; Lewin JS; Weiss CR
J Magn Reson Imaging; 2017 Apr; 45(4):1154-1162. PubMed ID: 27796061
[TBL] [Abstract][Full Text] [Related]
18. Image-guided percutaneous sclerotherapy of venous malformations of the head and neck: Clinical and MR-based volumetric mid-term outcome.
Vollherbst DF; Gebhart P; Kargus S; Burger A; Kühle R; Günther P; Hoffmann J; Bendszus M; Möhlenbruch MA
PLoS One; 2020; 15(10):e0241347. PubMed ID: 33119700
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
20. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
